Skip to content

DR. CARCHON

Active Private limited companyfounded 2001active for 25 yearsJan Baptist De Greeflaan 34, 1731 AsseKBO/BCE: BE 0473.917.056

Lifetime

20 annual accounts with figures on one time axis, 25 filings since 2001
peak of €357,475 in 2009
-€19,066▼ €42,306
lowest -€63,356 in 2006
-€26,854▼ €34,474
peak of €108,915 in 2024
€82,061▼ 24.7%
€14,136▲ 214%
peak of 4.3 FTE in 2006
-not published
Board1 name since 2021
1 director
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Gross margin from €23,240 to -€19,066Loss of €26,854Equity from €108,915 to €82,061Debts from €4,501 to €14,136Cash from €36,425 to €56,598

Key points

from the 2025 annual accounts

Liquidity

6.13 was 15.17 in 2024

Short-term debts rose from €4,501 to €14,136.

Filings

25 annual accounts since 2001
AprilJune31 JulyOctober20102020

Eight of the last ten came late. The 2024 accounts came in latest, 53 days after the end of the period.

Position in the sector

-€26,854

Lower net result than 93% of companies in education. Sector median €7,140 · 2,758 companies.

Turnover not published in the abbreviated or micro format

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 5,844 companies had the same profile as DR. CARCHON has now. Each dot stands for 15 companies, two years later.

84.3%
were still trading
13.6%
stopped another way
1.7%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a loss of 10% of the balance sheet or more

Another 0.4% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 5,844 companies, not a prediction for DR. CARCHON. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0473917056
Amendment of the articles · Legal-form change · Resignations & appointments Board composition: (director) · General meeting of 06-12-2023 · Gazette deed
First establishment Jan Baptist De Greeflaan 34, Asse
Incorporation published on 07-02-2001 · Gazette deed
All 38 events

Comparable companies

same main activity, similar in size and age
Company
DR. CARCHON Asse €96,197 -€19,066 85.3% -
Informer Ghent €88,271 €636 96.1% -
BIENNE Antwerp €79,698 -€410 92.1% -
ENNA Antwerp €136,436 -€7,273 87.0% -
Meligunis Knokke-Heist €93,641 -€16,632 -338.3% -
MentorMind Schilde €136,635 -€6,289 100.0% -
MELKI Mechelen €56,692 -€2,597 99.7% -

These companies have the same main activity as DR. CARCHON: other education (NACE 85599). They are comparable in size and age: total assets between €56,700 and €137,000, founded between 1994 and 2007.

Official details

Source: KBO
Status
Active since 25-01-2001Normal situation
Activity
Other educationNACE 85599
Joint committee
330Health institutions and services · annual accounts 2022
Establishment unit
2.174.920.5381731 Asse, since 01-01-2008
Financial year end
31 December
Peppol
Reachable since 15-07-2025
Company details

Annual accounts 2025

€96,197▼ 15.2%
Filing
Filed on 31-08-2026
Financials

Insights on DR. CARCHON

DR. CARCHON files the micro format. That format states no turnover. The gross margin fell from €265,380 in 2006 to -€19,066 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. CARCHON

What is the company number of DR. CARCHON?
The company number of DR. CARCHON is 0473.917.056. The VAT number is the same number with BE in front: BE 0473.917.056.
Where is DR. CARCHON based?
The registered office is at Jan Baptist De Greeflaan 34, 1731 Asse.Company details
What does DR. CARCHON do?
According to the KBO register, the main activity is other education (NACE 85599).
What is the legal form of DR. CARCHON?
DR. CARCHON is a private limited company (BV).
When was DR. CARCHON founded?
DR. CARCHON was founded on 25-01-2001.
Is DR. CARCHON still active?
Yes, DR. CARCHON is an active enterprise in the KBO register.
How many employees does DR. CARCHON have?
DR. CARCHON had an average of 0.5 full-time equivalents in financial year 2022, according to the filed annual accounts.Financials
Which joint committee does DR. CARCHON fall under?
In its 2022 annual accounts, DR. CARCHON states joint committee 330 (Health institutions and services).
What is the turnover of DR. CARCHON?
The annual accounts for financial year 2025 state no turnover. The abbreviated or micro format does not require it.
Is DR. CARCHON profitable?
In financial year 2025, DR. CARCHON made a loss of €26,854.
Where can I find the annual accounts of DR. CARCHON?
DR. CARCHON filed 25 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. CARCHON due?
DR. CARCHON must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.